Impact of suboptimal or inappropriate treatment on healthcare resource use and cost among patients with uncomplicated urinary tract infection: an analysis of integrated delivery network electronic health records

Table 3 Allergy history post-index uUTI

	Susceptible n = 1535		Not-susceptible n = 1030		Difference		Overall n = 2565
Variable	Mean proportion (%)	n	Mean proportion (%)	n	Difference	Standard mean difference	Mean proportion (%)	n
Any UTI antibiotic	5.0	77	5.44	56	0.42	0.019	5.19	133
Any first-line UTI antibiotic	2.93	45	2.82	29	− 0.12	0.007	2.88	74
Any second-line UTI antibiotic	1.11	17	1.36	14	0.25	0.023	1.21	31
Any third-line UTI antibiotic	1.30	20	2.23	23	0.93	0.071	1.68	43
Amoxicillin	0.33	5	0.87	9	0.55	0.071	0.55	14
Cefaclor	0.58	9	0.49	5	− 0.10	0.014	0.55	14
Cefdinir	0.20	3	0.00	0	− 0.20	0.063	0.12	3
Cefpodoxime	0.00	0	0.00	0	0.00		0.00	0
Ciprofloxacin	0.91	14	1.26	13	0.35	0.034	1.05	27
Fosfomycin	0.00	0	0.00	0	0.00		0.00	0
Levofloxacin	0.46	7	1.07	11	0.61	0.070	0.70	18
Nitrofurantoin	1.04	16	0.58	6	− 0.46	0.051	0.86	22
Ofloxacin	0.00	0	0.00	0	0.00		0.00	0
SXT	1.89	29	2.23	23	0.34	0.024	2.03	52

SXT trimethoprim/sulfamethoxazole, UTI urinary tract infection, uUTI uncomplicated urinary tract infection

ISSN: 2047-2994